Selank vs Semax: Simple Research Dosing Comparison Guide
Two Peptides, One Comparison
If you've been reading about research peptides, you've probably bumped into Selank and Semax in the same breath. They're both synthetic, both studied for brain-related effects, and both come from Russian neuroscience research. But they are not the same thing. Let's break it down simply.
What Is Selank?
Selank is a synthetic peptide made from a molecule called tuftsin — a natural compound your immune system already uses. Scientists added extra amino acids to make it more stable in the body. Research has focused on its calming, anxiety-reducing properties.[3]
One study found that Selank affects genes tied to the GABA system — the same brain system that anti-anxiety drugs like diazepam (Valium) target.[6] GABA is basically the brain's "slow down" signal. This helps explain why researchers are so interested in Selank for anxiety models.
What Is Semax?
Semax is built from a fragment of a hormone called ACTH. ACTH normally tells your adrenal glands to release stress hormones, but this particular fragment — positions 4 through 10 — doesn't do that. Instead, research suggests it supports brain-derived neurotrophic factor (BDNF), a protein that helps neurons survive and grow.[1]
Semax is more often studied for cognitive support, focus, and neuroprotection rather than anxiety relief. Think of it as the "sharpen things up" peptide in research settings, while Selank is more the "calm things down" peptide.
How Does Research Dosing Differ?
This is where many readers get confused. Research dosing for these peptides is often administered as nasal drops in studies, and the amounts used differ. Always check a reliable calculator when reading study protocols — unit conversions matter a lot here.
- Selank research doses: Studies commonly use doses around 300 µg/kg in animal models.[6] Human-focused research has used intranasal delivery in the microgram range.
- Semax research doses: Animal and early human studies also use intranasal delivery, with amounts typically in the low-to-mid microgram range per dose. Brain imaging research used single intranasal administrations.[2]
- Both peptides inhibit enzymes that break down enkephalins — natural pain and mood regulators — suggesting overlapping biochemical pathways.[4]
Quick Comparison List
- Origin: Selank → tuftsin analog | Semax → ACTH 4-10 analog
- Primary research focus: Selank → anxiety, mood | Semax → cognition, neuroprotection
- Main mechanism studied: Selank → GABAergic system[6] | Semax → BDNF pathways[1]
- Delivery in studies: Both primarily intranasal
- Shared finding: Both affect enzyme activity tied to mood regulation[4]
- Brain imaging: Both alter amygdala connectivity, but in different ways[2]
What Does Brain Imaging Show?
A fascinating 2020 study scanned the brains of 52 healthy people after they received either Selank, Semax, or a placebo. Using resting-state fMRI — a scan that watches how brain regions talk to each other at rest — researchers found that both peptides changed how the amygdala (your brain's alarm center) connected to the temporal cortex. But the changes were different for each peptide.[2] This supports the idea that they work through related but distinct paths.
Parkinson's Research: A Shared Test Case
Both peptides have also been studied in rat models of Parkinson's disease. Researchers damaged dopamine neurons with a toxic compound and then gave the rats either Semax or Selank. Selank reduced anxiety-like behavior in those rats — the same calming effect seen in healthy animals. Semax did not show the same anxiety effect in that model.[3] This again highlights their different profiles.
How to Choose What to Read About
Here's a simple rule of thumb for navigating the research literature:
- If you're curious about stress, anxiety, or mood research → start with Selank.
- If you're curious about memory, focus, or neuroprotection research → start with Semax.
- If you want to understand dosing units used in studies → use the calculator to convert between mcg/kg and flat microgram doses.
Both peptides are classed as neuroactive research compounds.[1] Neither is FDA-approved as a drug in the United States. This content is strictly for educational and research-reading purposes — always consult a qualified professional for any health decisions.
Sources
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200.
- Functional Connectomic Approach to Studying Selank and Semax Effects. — Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318.
- Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. — Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2017. PMID 28702721.
- [Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. — Bioorganicheskaia khimiia, 2001. PMID 11443939.
- Pharmacological Aspects of Neuro-Immune Interactions. — Current pharmaceutical design, 2018. PMID 28875850.
- Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission. — Frontiers in pharmacology, 2016. PMID 26924987.